202 related articles for article (PubMed ID: 15690207)
21. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
Fleming NI; Trivett MK; George J; Slavin JL; Murray WK; Moseley JM; Anderson RL; Thomas DM
Cancer Res; 2009 Sep; 69(18):7473-9. PubMed ID: 19723659
[TBL] [Abstract][Full Text] [Related]
22. Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?
Calogero RA; Quaglino E; Saviozzi S; Forni G; Cavallo F
Cancer Immunol Immunother; 2008 Nov; 57(11):1685-94. PubMed ID: 18286283
[TBL] [Abstract][Full Text] [Related]
23. The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression.
Baturin DA; Alimova IN; Anisimov VN; Popovich IG; Zabezhinski MA; Provinciali M; Mancini R; Franceschi C
Neuro Endocrinol Lett; 2001 Dec; 22(6):441-7. PubMed ID: 11781542
[TBL] [Abstract][Full Text] [Related]
24. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
Di Carlo E; Diodoro MG; Boggio K; Modesti A; Modesti M; Nanni P; Forni G; Musiani P
Lab Invest; 1999 Oct; 79(10):1261-9. PubMed ID: 10532589
[TBL] [Abstract][Full Text] [Related]
25. Correspondence re: Y. Chen et al., DNA vaccines encoding full-length or truncated neu induce protective immunity against neu-expressing mammary tumors. Cancer Res., 58: 1965-1971, 1998.
De Vecchi R; Pupa SM; Ménard S; Lollini PL
Cancer Res; 1999 Sep; 59(17):4471-2. PubMed ID: 10485500
[No Abstract] [Full Text] [Related]
26. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
[TBL] [Abstract][Full Text] [Related]
27. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
Eilon T; Barash I
BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
Mohanty K; Saha A; Pal S; Mallick P; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Breast Cancer Res Treat; 2007 Jul; 104(1):1-11. PubMed ID: 17004107
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
Rovero S; Amici A; Di Carlo E; Bei R; Nanni P; Quaglino E; Porcedda P; Boggio K; Smorlesi A; Lollini PL; Landuzzi L; Colombo MP; Giovarelli M; Musiani P; Forni G
J Immunol; 2000 Nov; 165(9):5133-42. PubMed ID: 11046045
[TBL] [Abstract][Full Text] [Related]
30. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
Quaglino E; Rolla S; Iezzi M; Spadaro M; Musiani P; De Giovanni C; Lollini PL; Lanzardo S; Forni G; Sanges R; Crispi S; De Luca P; Calogero R; Cavallo F
J Clin Invest; 2004 Mar; 113(5):709-17. PubMed ID: 14991069
[TBL] [Abstract][Full Text] [Related]
31. HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.
Manjili MH; Wang XY; Chen X; Martin T; Repasky EA; Henderson R; Subjeck JR
J Immunol; 2003 Oct; 171(8):4054-61. PubMed ID: 14530326
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice.
Gallo P; Dharmapuri S; Nuzzo M; Maldini D; Cipriani B; Forni G; Monaci P
Int J Cancer; 2007 Feb; 120(3):574-84. PubMed ID: 17096348
[TBL] [Abstract][Full Text] [Related]
33. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
Jacob J; Radkevich O; Forni G; Zielinski J; Shim D; Jones RF; Wei WZ
Cell Immunol; 2006 Apr; 240(2):96-106. PubMed ID: 16930573
[TBL] [Abstract][Full Text] [Related]
34. Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.
Pupa SM; Invernizzi AM; Forti S; Di Carlo E; Musiani P; Nanni P; Lollini PL; Meazza R; Ferrini S; Menard S
Gene Ther; 2001 Jan; 8(1):75-9. PubMed ID: 11402305
[TBL] [Abstract][Full Text] [Related]
35. Immunization in tumor prevention.
Forni G; Curcio C; Spadaro M; Iliffe J; Quaglino E; Di Carlo E; Musiani P; Lollini PL
Int Immunopharmacol; 2003 Aug; 3(8):1151-8. PubMed ID: 12860170
[TBL] [Abstract][Full Text] [Related]
36. Clinical translation of peptide-based vaccine trials: the HER-2/neu model.
Disis ML; Knutson KL; McNeel DG; Davis D; Schiffman K
Crit Rev Immunol; 2001; 21(1-3):263-73. PubMed ID: 11642608
[TBL] [Abstract][Full Text] [Related]
37. Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent.
Nanni P; Landuzzi L; Nicoletti G; De Giovanni C; Rossi I; Croci S; Astolfi A; Iezzi M; Di Carlo E; Musiani P; Forni G; Lollini PL
J Immunol; 2004 Aug; 173(4):2288-96. PubMed ID: 15294941
[TBL] [Abstract][Full Text] [Related]
38. Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice.
Masuelli L; Marzocchella L; Focaccetti C; Lista F; Nardi A; Scardino A; Mattei M; Turriziani M; Modesti M; Forni G; Schlom J; Modesti A; Bei R
Cancer Immunol Immunother; 2010 Aug; 59(8):1247-58. PubMed ID: 20364378
[TBL] [Abstract][Full Text] [Related]
39. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.
Jacob JB; Kong YC; Nalbantoglu I; Snower DP; Wei WZ
J Immunol; 2009 May; 182(9):5873-81. PubMed ID: 19380836
[TBL] [Abstract][Full Text] [Related]
40. Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo.
Allen SD; Garrett JT; Rawale SV; Jones AL; Phillips G; Forni G; Morris JC; Oshima RG; Kaumaya PT
J Immunol; 2007 Jul; 179(1):472-82. PubMed ID: 17579068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
